PLUS: Ozempic, Wegovy, Semaglutide, OH MY! — After explosive growth in the first year of the pandemic, the amount of VC funding flowing into digital health in 2022 was about half of what it was in 2021. Meanwhile, exit opportunities have seemingly dried up. In this week’s episode of my podcast, we dive into the macroeconomic landscape…